StreetInsider.com News Articles

UPDATE – MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing In Preparation for First Commercial Pilot.

Wed, 14 Oct 2026 10:22:00 -0400

VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) (the “Company” or “MindBio”), a biotechnology company advancing the commercialisation of AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce that it has completed the manufacture of its next-generation Edge AI Intoxication Detection Kiosk.

The newly manufactured hardware kiosk improves on an initial prototype produced in June this year. The new hardware is designed to support MindBio's proprietary Voice AI intoxication detection technology. The Company is continuing to refine, integrate and test its software, which

UPDATE – MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing In Preparation for First Commercial Pilot.

Wed, 14 Oct 2026 10:22:00 -0400

UPDATE – MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing In Preparation for First Commercial Pilot.

Wed, 14 Oct 2026 10:22:00 -0400

UPDATE – MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing In Preparation for First Commercial Pilot.

Wed, 14 Oct 2026 10:22:00 -0400

MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing Towards In Preparation for First Commercial Pilot.

Wed, 14 Oct 2026 09:43:00 -0400

MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing Towards In Preparation for First Commercial Pilot.

Wed, 14 Oct 2026 09:43:00 -0400

MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing Towards In Preparation for First Commercial Pilot.

Wed, 14 Oct 2026 09:43:00 -0400

MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing Towards In Preparation for First Commercial Pilot.

Wed, 14 Oct 2026 09:43:00 -0400

MindBio Completes Manufacture and Delivery of First Prototype Edge AI Intoxication and Fatigue Detection Kiosks

Tue, 09 Jun 2026 07:00:00 -0400

VANCOUVER, British Columbia, June 09, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializing AI-driven voice analytics for intoxication and fatigue detection, is pleased to announce the Company has completed the manufacture of and delivered its first prototype Edge AI Intoxication Detection Kiosks. The first prototypes are a hardware and software solution designed for office and industrial use to detect intoxication and fatigue and improve safety in the workplace.

35f33c2a-37c3-4d2b-bcfd-17b972f43a9d VANCOUVER, British Columbia, June 09, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializing AI-driven voice analytics for intoxication and fatigue detection, is pleased to announce the Company has completed the manufacture of and delivered its first prototype Edge AI Intoxication Detection Kiosks. The first prototypes are a hardware and software solution designed for office and industrial use to detect intoxication and fatigue and improve safety in the workplace.

35f33c2a-37c3-4d2b-bcfd-17b972f43a9d MindBio is on track for delivery of its initial commercial prototype this quarter.

VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.

MindBio’s enterprise solution

MindBio Launches Intox AI™ in Major Advancement for Drug Use Detection